TY - JOUR
T1 - A flow cytometric study of reagent cells to resolve ABO typing discrepancy
AU - Maracaja, Danielle L.V.
AU - Qiao, Jesse
AU - Salazar, Tomas
AU - Barry, James
AU - LaForce, Karen
AU - Holder, Kenneth
AU - Olson, John D.
N1 - Publisher Copyright:
© American Society for Clinical Pathology, 2020. All rights reserved.
PY - 2021/1/1
Y1 - 2021/1/1
N2 - Objectives: RBC alloantibodies can lead to ABO grouping discrepancies unrelated to A or B antigens or antibodies posing challenges in the blood bank testing. Routine blood bank testing and flow cytometry were used to immunophenotype reagent cells and elucidate the cause of ABO discrepancies in two patients. Methods: ABO discrepancy was identified in two patients after transfusion with several units of RBCs. For both patients, the pretransfusion type and screen demonstrated blood group A. Eight and 16 days later, both patients showed an apparent antibody to reagent group A cells, which prompted additional study with patients’ samples and flow cytometric testing of commercial reagent cells. Results: In both patients’ specimens, posttransfusion evaluation demonstrated an emerging antibody to the Kell antigen (K). The RBCs of both patients typed negative for K, and both were transfused with K-positive RBCs. Flow cytometric analysis of reagent RBCs demonstrated that five of seven lot numbers were positive for K. Conclusions: Emerging anti-K antibody led to agglutination of the K-positive reagent A1 cells, highlighting the importance of considering RBC alloantibodies and the composition of reagent cells when interpreting cases with an apparent ABO grouping discrepancy.
AB - Objectives: RBC alloantibodies can lead to ABO grouping discrepancies unrelated to A or B antigens or antibodies posing challenges in the blood bank testing. Routine blood bank testing and flow cytometry were used to immunophenotype reagent cells and elucidate the cause of ABO discrepancies in two patients. Methods: ABO discrepancy was identified in two patients after transfusion with several units of RBCs. For both patients, the pretransfusion type and screen demonstrated blood group A. Eight and 16 days later, both patients showed an apparent antibody to reagent group A cells, which prompted additional study with patients’ samples and flow cytometric testing of commercial reagent cells. Results: In both patients’ specimens, posttransfusion evaluation demonstrated an emerging antibody to the Kell antigen (K). The RBCs of both patients typed negative for K, and both were transfused with K-positive RBCs. Flow cytometric analysis of reagent RBCs demonstrated that five of seven lot numbers were positive for K. Conclusions: Emerging anti-K antibody led to agglutination of the K-positive reagent A1 cells, highlighting the importance of considering RBC alloantibodies and the composition of reagent cells when interpreting cases with an apparent ABO grouping discrepancy.
KW - ABO typing discrepancy
KW - Anti-K
KW - Flow cytometry
KW - Kell alloantibodies
KW - Kell-positive reagent cells
KW - Posttransfusion discrepancy
UR - http://www.scopus.com/inward/record.url?scp=85099326534&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099326534&partnerID=8YFLogxK
U2 - 10.1093/ajcp/aqaa117
DO - 10.1093/ajcp/aqaa117
M3 - Article
C2 - 33049048
AN - SCOPUS:85099326534
SN - 0002-9173
VL - 155
SP - 117
EP - 123
JO - American journal of clinical pathology
JF - American journal of clinical pathology
IS - 1
ER -